China

Showing 15 posts of 258 posts found.

gdd_logo_002

BeiGene to develop $330 million biologics plant

March 7, 2017
Manufacturing and Production, Research and Development BeiGene, China, Guangzhou

BeiGene, a Chinese biotech company, and Guangzhou GET Technology Development, an affiliate of Guangzhou Development District, will partner in the …

the-chinese-national-flag-1752046_960_720

China’s insurance expansion boon to global pharma

February 23, 2017
Sales and Marketing AstraZeneca, China, GSK, Shire

China has expanded the list of medicines that are covered on basic medical insurance schemes, named China’s National Reimbursement Drug …

medication

Generic version of top-selling lung cancer drug hits Chinese market

February 20, 2017
Sales and Marketing China, generics

A generic version of AstraZeneca’s Iressa (gefitinib) has been released onto the Chinese market, named Yiruike. The generic undercuts the …

shutterstock_57369385

WCO seizes 113m fake Indian & Chinese drugs in Africa in 10 days

February 3, 2017
Manufacturing and Production, Medical Communications, Sales and Marketing Africa, China, Counterfeit drugs, India, World Customs Organisation

The World Customs Organisation (WCO) has revealed insight into the extent of the global drug counterfeiting crisis with the announcement …

verily_company_logo

Google’s life sciences business gains $800 million funding in pivot to Asia

January 27, 2017
Medical Communications, Sales and Marketing China, Temasek, Verily, google

Verily, a life sciences company owned by Alphabet, Google’s umbrella company, has announced that it has received $800 million in …

china_pic

Top Pharmaceutical Markets 2016: China

December 9, 2016
Business Services, Manufacturing and Production, Medical Communications, Sales and Marketing China, market analysis

Originally featured in Pharmafile Autumn 2016, a report from the United States International Trade Administration sheds light on the Chinese …

kymab

Chinese investors push Kymab backing to $100 million

November 28, 2016
Sales and Marketing Bill & Melina Gates Foundation, China, kymab

Kymab, the UK-based antibody biopharmaceutical group, announced that it has secured $100 million in funding. The company raised the funds …

dna-163466

China conducts first gene-editing human trial

November 21, 2016
Research and Development, Sales and Marketing China, DNA, cas9, crispr

China has used Crispr/Cas9 gene-editing technology to edit the DNA of a human subject, suffering from metastatic lung cancer. This …

Merck KGaA invests €250 million in production in China

November 4, 2016
Manufacturing and Production China, Merck KGaA, Nantong, manufacturing

Merck KGaA inaugurated their Nantong pharmaceutical plant on 4 November. At the same time, Merck also announced that it plans …

fda2outsideweb

FDA issues warning letter after Chinese firm impedes investigation

November 2, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, FDA

The US Food and Drugs Administration (FDA) has issued a Chinese firm with a warning letter after claims it intentionally …

shutterstock_168864905

GSK agrees to $20m settlement for Chinese bribery allegation

October 3, 2016
Business Services, Sales and Marketing China, GSK, GlaxoSmithKline

GlaxoSmithKline has agreed to settle a bribery allegation in China with a payment of $20 million to the US Securities …

china-pharmaceutical-industry

80% of Chinese clinical trials’ data fabricated

September 28, 2016
Manufacturing and Production, Research and Development China, Fabrication, corruption, report

The government review of clinical trial practise involved 1,622 programs of new pharmaceutical drugs waiting upon government approval to begin …

mr058666-web

Merck says its Erbitux in combination with Folfox improves outcomes in colorectal cancer

July 4, 2016
Research and Development, Sales and Marketing Cancer, China, ESMO, Merck, colorectal cancer, drug trial, research, study

Merck said late-stage trials for its Erbitux (cetuximab) in combination with Folfox significantly improved progression free survival in metastatic colorectal …

Pfizer to invest about $350 million in China biotech facility, first in Asia

June 29, 2016
Research and Development, Sales and Marketing Biotech Plant, China, Pfizer, research

US pharma giant Pfizer (NYSE: PFE) said it will invest about $350 million for a global biotechnology center in the …

dollars_medicines

China to cut prices of GSK, AstraZeneca drugs

May 23, 2016
Sales and Marketing AstraZeneca, China, GSK, drug prices

Chinese health authorities have announced steps to cut the prices of three costly drugs in their latest attempt to reduce …

The Gateway to Local Adoption Series

Latest content